Study Identifies THC Blood Levels of 2-5 ng/ml as the Threshold Where Driving Impairment Begins | Research

The takeaway

A controlled study of 20 recreational cannabis users found impairment began at serum THC concentrations of 2-5 ng/ml, with 75-90% showing impairment at 5-10 ng/ml and 100% impaired above 30 ng/ml, providing a framework for legal driving limits.

Read this if you want to understand at what blood THC level cannabis starts to impair driving-related abilities.

Impairment began at 2-5 ng/ml THC; 100% impaired above 30 ng/ml

What the researchers found

Twenty recreational cannabis users participated in a double-blind, placebo-controlled, three-way crossover study with single doses of 0, 250, and 500 micrograms/kg THC by smoking. Performance tests measuring driving-related skills were conducted from 15 minutes to 6 hours post-smoking.

THC concentrations in serum and oral fluid showed a strong linear relationship. However, the linear relationship between THC concentration and performance impairment was weak, meaning blood levels alone poorly predicted the degree of impairment.

A more useful approach emerged from examining the proportion of observations showing impairment at each THC level. Initial significant impairment appeared at 2-5 ng/ml serum THC. At 5-10 ng/ml, 75-90% of observations showed significant impairment. Above 30 ng/ml, 100% of observations showed significant impairment in every test.

Why it matters

This study directly addressed one of the most important practical questions in cannabis policy: at what blood THC concentration does impairment begin? The finding of a 2-5 ng/ml threshold has been influential in establishing legal per se limits for drug-impaired driving in several jurisdictions.

The numbers in context

20 participants. Doses: 0, 250, 500 micrograms/kg THC. Impairment threshold: 2-5 ng/ml serum THC. 75-90% impaired at 5-10 ng/ml. 100% impaired above 30 ng/ml. Strong linear relationship between serum and oral fluid THC. Weak linear relationship between THC and impairment magnitude.

How the study worked

Double-blind, placebo-controlled, three-way crossover study. 20 recreational cannabis users. Single doses of 0, 250, and 500 micrograms/kg THC by smoking. Tests: Critical tracking task (perceptual-motor control), Stop signal task (motor impulsivity), Tower of London (cognitive function). Blood and oral fluid collected throughout.

What this study cannot tell us

Only 20 participants, all recreational users (tolerance may affect results). Only smoked cannabis tested. Only three cognitive tasks used, which may not capture all driving-relevant skills. Laboratory setting does not replicate actual driving conditions.

How to read the evidence

Well-designed double-blind, placebo-controlled crossover study. Small sample but rigorous methodology with pharmacokinetic correlation.

When this study was published

Published in 2006. This study has been influential in establishing per se THC limits for driving in several countries and states.

The bigger picture

Several jurisdictions have adopted per se limits of 1-5 ng/ml THC based partly on this and similar research. The finding that a simple linear dose-response model does not work, but threshold-based impairment probability does, has influenced both legal and scientific approaches to the cannabis-driving question.

Questions still open

Do regular heavy cannabis users show impairment at the same THC thresholds as recreational users? How do these laboratory thresholds translate to actual on-road driving performance?

Common questions

At what THC level does impairment start?

This study found initial significant impairment at serum THC concentrations of 2-5 ng/ml. At 5-10 ng/ml, 75-90% of performance observations showed impairment. Above 30 ng/ml, impairment was found in 100% of observations.

Can a blood test accurately measure cannabis impairment?

THC blood levels do not linearly predict the degree of impairment (someone with twice the THC is not necessarily twice as impaired). However, the probability of being impaired increases progressively with THC concentration, making threshold-based limits a useful approach.

Read the original research

Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.

Drug and alcohol dependence, 85(2), 114-22

View on PubMed ↗

Citation

Ramaekers, J G; Moeller, M R; van Ruitenbeek, P; Theunissen, E L; Schneider, E; Kauert, G. (2006). Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.. Drug and alcohol dependence, 85(2), 114-22.